almitrine has been researched along with yohimbine in 49 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 24 (48.98) | 18.7374 |
| 1990's | 21 (42.86) | 18.2507 |
| 2000's | 3 (6.12) | 29.6817 |
| 2010's | 1 (2.04) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benzi, G; Curti, D; Dagani, F; Marzatico, F; Pastoris, O; Villa, RF | 1 |
| Arnaboldi, R; Geroldi, D; Ghigini, B; Gorini, A; Villa, RF | 1 |
| Benzi, G; Curti, D | 1 |
| Guez, D; Malbezin, M; Piette, F; Poitrenaud, J; Sebban, C | 2 |
| Guez, D | 2 |
| Cattelin, F; Depresseux, JC; Franck, G; Van Cauwenberge, H | 1 |
| Guez, D; Malbezin, M; Schatz, C; Sebban, C; Tesolin, B | 1 |
| Allain, H; Bentué-Ferrer, D; Decombe, R; Reymann, JM; Schatz, C | 1 |
| Carbonin, PU; Cattelin, F; Gemma, A; Greco, A; Pisanti, P | 1 |
| Berthaux, P; Coulomb, B; Sebban, C; Tesolin, B | 1 |
| Benvenuti, C; Degos, JD; Gherardi, R; Lejonc, JL; Louarn, F; Perrier, M; Schaeffer, A | 1 |
| Pastoris, O; Villa, RF | 1 |
| Depresseux, JC; Franck, G; Van Cauwenberge, H | 1 |
| Guez, D; Sebban, C; Tesolin, B | 1 |
| Azzaro, E; Fichera, G; Rapisarda, V | 1 |
| Borzeix, MG; Cahn, J | 1 |
| Labrid, C | 1 |
| Cahn, J; Cahn, R | 1 |
| Blondin, P; Bordes, LR; Soubeyrand, L | 1 |
| Sebban, C | 2 |
| Mémin, Y | 2 |
| Anderer, P; Grünberger, J; Linzmayer, L; Saletu, B | 1 |
| Meyer, B | 1 |
| Devissaguet, M | 1 |
| Delorme, P | 2 |
| Actis, H; Dellazuana, O; Duhault, J; Roman, F | 1 |
| Berthaux, P; Sebban, C | 1 |
| Berthaux, P; Laforestrie, R | 1 |
| Callis, A; Dorance, M; Magnan de Bornier, B | 1 |
| Arnaboldi, R; Benzi, G; Dossena, M; Foppa, P; Gorini, A; Pastoris, O; Villa, RF | 1 |
| Arnaboldi, R; Benzi, G; Ghigini, B; Gorini, A; Villa, RF | 1 |
| Chan, P; Guez, D; Hu, P; Li, Y; Sarbach, SD; Zheng, Z | 1 |
| Debure, L; Ginovart, N; Pujol, JF; Rousset, C; Weissmann, D | 1 |
| Chan, P | 1 |
| Laurent, B; Poitrenaud, J; Sebban, C | 1 |
| Li, SW | 1 |
| Benzi, G | 1 |
| Allain, H; Bentué-Ferrer, D | 2 |
| Li, J; Li, S; Long, J; Ma, Z; Xu, Z; Zhang, Z | 1 |
| Li, ZH; Shi, YM; Xu, WJ; Zou, YH | 1 |
| Hao, Z; Liu, GJ; Liu, M; Teng, J; Wu, B; Wu, T; Yang, W | 1 |
9 review(s) available for almitrine and yohimbine
| Article | Year |
|---|---|
[Duxil and cognitive deficiency in the elderly. Results of a 6-month controlled multicenter study].
Topics: Aged; Aged, 80 and over; Almitrine; Cognition Disorders; Double-Blind Method; Drug Combinations; Humans; Piperazines; Psychometrics; Time Factors; Yohimbine | 1990 |
A review of the EEG effects of the combination of almitrine and raubasine in animals and humans.
Topics: Aged; Aging; Almitrine; Animals; Drug Combinations; Electroencephalography; Humans; Rats; Secologanin Tryptamine Alkaloids; Yohimbine | 1990 |
Progress in understanding the pathophysiology of cerebral ischemia: the almitrine-raubasine approach.
Topics: Almitrine; Animals; Brain Ischemia; Disease Models, Animal; Drug Combinations; Humans; Secologanin Tryptamine Alkaloids; Yohimbine | 1990 |
[Experimental models in cerebral ischemia: application to the study of duxil].
Topics: Almitrine; Animals; Brain Ischemia; Cats; Cerebral Arteries; Disease Models, Animal; Dogs; Drug Combinations; Gerbillinae; Humans; Piperazines; Rabbits; Rats; Yohimbine | 1988 |
Pathophysiology of postischemic hypoxia and cerebral protection: implications of the almitrine and raubasine combination.
Topics: Almitrine; Animals; Brain Ischemia; Drug Combinations; Hypoxia, Brain; Ischemic Attack, Transient; Neuroprotective Agents; Piperazines; Secologanin Tryptamine Alkaloids; Treatment Outcome; Yohimbine | 1995 |
Quantitative electroencephalography in aging brain and cerebrovascular disease: the effects of almitrine-raubasine.
Topics: Aging; Almitrine; Animals; Brain; Cerebrovascular Disorders; Drug Combinations; Electroencephalography; Humans; Neuroprotective Agents; Rats; Secologanin Tryptamine Alkaloids; Yohimbine | 1995 |
Pharmacological features of an almitrine-raubasine combination. Activity at cerebral levels.
Topics: Almitrine; Blood Glucose; Brain; Cerebrovascular Circulation; Drug Combinations; Energy Metabolism; Humans; Neuroprotective Agents; Oxygen; Partial Pressure; Yohimbine | 1998 |
Clinical efficacy of almitrine-raubasine. An overview.
Topics: Aged; Aging; Almitrine; Clinical Trials as Topic; Cognition Disorders; Drug Combinations; Humans; Ischemia; Neuroprotective Agents; Retinal Vessels; Treatment Outcome; Yohimbine | 1998 |
Almitrine-Raubasine combination for dementia.
Topics: Aged; Almitrine; Dementia; Drug Combinations; Humans; Middle Aged; Neuroprotective Agents; Yohimbine | 2011 |
12 trial(s) available for almitrine and yohimbine
| Article | Year |
|---|---|
[Duxil and cognitive deficiency in the elderly. Results of a 6-month controlled multicenter study].
Topics: Aged; Aged, 80 and over; Almitrine; Cognition Disorders; Double-Blind Method; Drug Combinations; Humans; Piperazines; Psychometrics; Time Factors; Yohimbine | 1990 |
Almitrine-raubasine and cognitive impairment in the elderly: results of a 6-month controlled multicenter study.
Topics: Aged; Aged, 80 and over; Almitrine; Anxiety; Cognition Disorders; Depression; Double-Blind Method; Drug Combinations; Female; Humans; Male; Memory; Psychological Tests; Secologanin Tryptamine Alkaloids; Yohimbine | 1990 |
Efficacy of almitrine-raubasine in cognitive disorders of aging: a double-blind, placebo-controlled, clinical and psychometric study.
Topics: Aged; Aged, 80 and over; Aging; Almitrine; Cognition Disorders; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Psychological Tests; Psychometrics; Secologanin Tryptamine Alkaloids; Yohimbine | 1990 |
[Psychometric evaluation of the effects of an almitrine-raubasine combination in the intellectual deterioration of aged subjects. A double-blind controlled trial versus placebo].
Topics: Aged; Almitrine; Anti-Inflammatory Agents, Non-Steroidal; Central Nervous System Stimulants; Clinical Trials as Topic; Dementia; Double-Blind Method; Drug Evaluation; Female; Humans; Male; Middle Aged; Piperazines; Psychometrics; Secologanin Tryptamine Alkaloids; Yohimbine | 1987 |
Double-blind, placebo-controlled quantitative EEG and psychometric studies in elderlies on vigilance-promoting effects of an almitrine/raubasine combination (Duxil).
Topics: Aged; Almitrine; Arousal; Cognition; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Electroencephalography; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Piperazines; Psychomotor Performance; Random Allocation; Yohimbine | 1988 |
[A multicenter study of tinnitus. Epidemiology and therapy].
Topics: Almitrine; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Nicergoline; Piperazines; Plant Extracts; Random Allocation; Secologanin Tryptamine Alkaloids; Tinnitus; Yohimbine | 1986 |
[Comparison of the effects of almitrine, raubasine and 5023 SE on arterial oxygen desaturation during exercise].
Topics: Almitrine; Arteries; Drug Combinations; Humans; Middle Aged; Oxygen; Physical Exertion; Piperazines; Secologanin Tryptamine Alkaloids; Yohimbine | 1983 |
[Effects of 5023 SE on PaO2 at rest in elderly patients with cerebral impairment. A double-blind cross-over trial versus placebo].
Topics: Aged; Almitrine; Brain Diseases; Dementia; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Oxygen; Partial Pressure; Piperazines; Time Factors; Yohimbine | 1983 |
[Demonstration of the therapeutic activity of 5023 SE on intellectual and psychomotor efficacy in elderly impaired patients. Double-blind controlled study versus placebo].
Topics: Aged; Almitrine; Clinical Trials as Topic; Dementia; Double-Blind Method; Drug Combinations; Humans; Mental Processes; Piperazines; Psychomotor Performance; Reaction Time; Yohimbine | 1983 |
Memory disorders in 8,037 elderly patients with age-associated memory impairment: multicenter trial with a 6-month follow-up under almitrine-raubasine.
Topics: Aged; Aged, 80 and over; Aging; Almitrine; Drug Combinations; Family Practice; Follow-Up Studies; Humans; Memory Disorders; Middle Aged; Neuroprotective Agents; Secologanin Tryptamine Alkaloids; Yohimbine | 1995 |
Assessment of the therapeutic activity of a combination of almitrine and raubasine on functional rehabilitation following ischaemic stroke.
Topics: Aged; Almitrine; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Neuroprotective Agents; Recovery of Function; Stroke; Stroke Rehabilitation; Treatment Outcome; Yohimbine | 2004 |
[Clinical research of effect of Yishen Yangnao capsule on vascular dementia].
Topics: Activities of Daily Living; Aged; Almitrine; Capsules; Dementia, Vascular; Drug Combinations; Drugs, Chinese Herbal; Event-Related Potentials, P300; Female; Humans; Male; Medicine, Chinese Traditional; Middle Aged; Neuroprotective Agents; Phytotherapy; Treatment Outcome; Yohimbine | 2007 |
29 other study(ies) available for almitrine and yohimbine
| Article | Year |
|---|---|
Sequential damage in mitochondrial complexes by peroxidative stress.
Topics: Almitrine; Animals; Cyclohexanones; Cytochrome c Group; Electron Transport; Electron Transport Complex IV; gamma-Aminobutyric Acid; Glutathione; Male; Mitochondria; NADH Dehydrogenase; Oxidation-Reduction; Pantothenic Acid; Prosencephalon; Rats; Rats, Inbred Strains; Succinate Dehydrogenase; Yohimbine | 1991 |
Factors involved in drug interference on enzyme activities of three mitochondrial populations from rat hippocampus.
Topics: Adaptation, Physiological; Almitrine; Animals; Energy Metabolism; Hippocampus; Male; Mitochondria; Rats; Rats, Inbred Strains; Secologanin Tryptamine Alkaloids; Synaptosomes; Yohimbine | 1991 |
Role of synaptosomal enzymatic alterations and drug treatment in brain aging.
Topics: Aging; Almitrine; Animals; Brain; Citrate (si)-Synthase; Electron Transport Complex IV; Glucosephosphate Dehydrogenase; Male; Papaverine; Phosphofructokinase-1; Pyruvate Dehydrogenase Complex; Rats; Rats, Inbred Strains; Secologanin Tryptamine Alkaloids; Synaptosomes; Yohimbine | 1990 |
Long-term effects and safety of almitrine-raubasine in age-associated cognitive decline.
Topics: Aged; Aging; Almitrine; Cognition Disorders; Drug Combinations; Female; Humans; Male; Middle Aged; Secologanin Tryptamine Alkaloids; Time Factors; Yohimbine | 1990 |
Metabolic and circulatory evaluation of cerebral ischemic accident in humans by positron emission tomography: a pilot study with almitrine-raubasine.
Topics: Aged; Almitrine; Brain Ischemia; Cerebrovascular Circulation; Drug Combinations; Female; Humans; Male; Middle Aged; Oxygen Consumption; Pilot Projects; Secologanin Tryptamine Alkaloids; Tomography, Emission-Computed; Yohimbine | 1990 |
Comparative effects of almitrine and raubasine, singly and in combination, on electroencephalographic activity in young and old rats.
Topics: Aging; Almitrine; Animals; Brain; Drug Combinations; Electroencephalography; Injections, Intraperitoneal; Male; Piperazines; Random Allocation; Rats; Rats, Inbred Strains; Secologanin Tryptamine Alkaloids; Yohimbine | 1989 |
Peripheral neuropathy in patients treated with almitrine dimesylate.
Topics: Aged; Almitrine; Biopsy; Body Weight; Central Nervous System Stimulants; Drug Therapy, Combination; Evoked Potentials; Female; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Neural Conduction; Peripheral Nervous System Diseases; Peroneal Nerve; Piperazines; Secologanin Tryptamine Alkaloids; Time Factors; Yohimbine | 1985 |
[Effects of aging and various pharmacologic agents on the brain energy metabolism in the course of post-hypoglycemic recuperation in the rat].
Topics: Adenosine Triphosphate; Aging; Almitrine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain; Central Nervous System Stimulants; Glucose; Hypoglycemia; Male; Phosphocreatine; Piperazines; Rats; Rats, Inbred Strains; Secologanin Tryptamine Alkaloids; Sodium Chloride; Time Factors; Yohimbine | 1987 |
[Metabolic and blood circulation evaluation of acute ischemic cerebral accident in humans using positron emission tomography].
Topics: Acute Disease; Aged; Almitrine; Anti-Inflammatory Agents, Non-Steroidal; Brain Ischemia; Central Nervous System Stimulants; Cerebrovascular Circulation; Drug Combinations; Female; Humans; Male; Middle Aged; Oxygen Consumption; Piperazines; Secologanin Tryptamine Alkaloids; Tomography, Emission-Computed; Yohimbine | 1987 |
[Quantified electroencephalogram: value in the evaluation of therapy of cerebral aging].
Topics: Almitrine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Central Nervous System Stimulants; Cerebral Cortex; Clonidine; Dementia; Drug Combinations; Drug Evaluation; Electroencephalography; Humans; Piperazines; Rats; Secologanin Tryptamine Alkaloids; Yohimbine | 1987 |
Experimental approach of treatment of cerebral ischemia by a combination of raubasine and almitrine.
Topics: Almitrine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Avoidance Learning; Brain; Central Nervous System Stimulants; Drug Therapy, Combination; Fatty Acids, Nonesterified; Ischemic Attack, Transient; Male; Necrosis; Piperazines; Rats; Rats, Inbred Strains; Secologanin Tryptamine Alkaloids; Water-Electrolyte Balance; Yohimbine | 1987 |
[Evaluation of acute and chronic cerebral ischemia in man by positron and single photon emission tomography: application to the study of duxil].
Topics: Acute Disease; Aged; Almitrine; Brain Ischemia; Cerebrovascular Circulation; Chronic Disease; Drug Combinations; Female; Humans; Male; Middle Aged; Oxygen Consumption; Piperazines; Tomography, Emission-Computed; Yohimbine | 1988 |
Curative effect of an almitrine-raubasine combination in the postischemic syndrome following transient cerebral ischemia in dogs.
Topics: Almitrine; Animals; Blood Flow Velocity; Cerebral Arteries; Cerebrovascular Circulation; Dogs; Drug Combinations; Hypoxia, Brain; Ischemic Attack, Transient; Piperazines; Secologanin Tryptamine Alkaloids; Time Factors; Yohimbine | 1988 |
[First Forum on Updates on Cerebral Ischemia Pathology. Seville, 1-4 October 1987. Proceedings].
Topics: Almitrine; Brain Ischemia; Drug Combinations; Humans; Piperazines; Yohimbine | 1988 |
[Evaluation of the activity of duxil in the endocochlear hypoacusis of ischemic origin].
Topics: Adult; Aged; Almitrine; Audiometry; Cochlea; Drug Combinations; Evoked Potentials, Auditory; Female; Hearing Disorders; Humans; Ischemia; Labyrinth Diseases; Male; Middle Aged; Piperazines; Yohimbine | 1988 |
[Exploration of the effects of duxil on the central nervous system by quantified electroencephalography].
Topics: Aged; Aging; Almitrine; Animals; Brain; Drug Combinations; Electroencephalography; Humans; Piperazines; Rats; Yohimbine | 1988 |
[Evaluation of the therapeutic effect of duxil in chronic cerebral insufficiency. Analysis of 4636 patients at cerebrovascular risk].
Topics: Aged; Almitrine; Attention; Brain Ischemia; Chronic Disease; Drug Combinations; Humans; Hypoxia, Brain; Memory; Middle Aged; Piperazines; Risk Factors; Yohimbine | 1988 |
[Pharmacological approach to a treatment of senescence and cerebrovascular deficiencies related to hypoxia. Application to 5023 SE].
Topics: Aging; Almitrine; Animals; Cerebrovascular Circulation; Cerebrovascular Disorders; Disease Models, Animal; Dogs; Drug Combinations; Glucose; Humans; Hypoxia, Brain; Neurons; Oxygen Consumption; Piperazines; Rabbits; Rats; Yohimbine | 1983 |
[Ultrastructural study of acute ischemia at the cerebral level. Effects of 5023 SE].
Topics: Acute Disease; Almitrine; Animals; Brain Ischemia; Disease Models, Animal; Drug Combinations; Microscopy, Electron; Piperazines; Rabbits; Telencephalon; Time Factors; Yohimbine | 1983 |
[Ultrastructural study of acute ischemia at the peripheral level. Effects of 5023 SE].
Topics: Acute Disease; Almitrine; Animals; Brain Ischemia; Carotid Arteries; Disease Models, Animal; Drug Combinations; Endothelium; Microscopy, Electron; Piperazines; Rabbits; Yohimbine | 1983 |
[Effects of 5023 SE on experimental cerebral ischemia in gerbils].
Topics: Almitrine; Animals; Brain Ischemia; Disease Models, Animal; Drug Combinations; Gerbillinae; Piperazines; Time Factors; Yohimbine | 1983 |
[Effect of a tissue oxygenator (almitrine + raubasine) on the metabolism of 2,3-diphosphoglycerate of rabbits submitted by hypoxia].
Topics: Almitrine; Animals; Diphosphoglyceric Acids; Erythrocytes; Hypoxia; Kinetics; Oxygen; Partial Pressure; Piperazines; Rabbits; Secologanin Tryptamine Alkaloids; Triazines; Yohimbine | 1980 |
Modifications by chronic intermittent hypoxia and drug treatment on skeletal muscle metabolism.
Topics: Adenine Nucleotides; Almitrine; Animals; Chronic Disease; Energy Metabolism; Glycogen; Glycolysis; Guanidines; Hypoxia; Male; Mitochondria, Muscle; Muscle, Skeletal; Papaverine; Pinacidil; Rats; Rats, Wistar; Stereoisomerism; Time Factors; Vasodilator Agents; Yohimbine | 1995 |
Modifications by hypoxia and drug treatment of cerebral ATPase plasticity.
Topics: Adenosine Triphosphatases; Almitrine; Animals; Ca(2+) Mg(2+)-ATPase; Calcium-Transporting ATPases; Cerebral Cortex; Clonidine; Hypoxia, Brain; Kinetics; Papaverine; Rats; Reference Values; Sodium-Potassium-Exchanging ATPase; Synaptic Membranes; Synaptic Vesicles; Synaptosomes; Yohimbine | 1994 |
Neurologic and histologic evaluation of almitrine+raubasine (Duxil) in middle cerebral artery occlusion in cats.
Topics: Almitrine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Brain; Brain Chemistry; Brain Ischemia; Cats; Cerebral Arteries; Female; Glycogen; Male; Mitochondria; Secologanin Tryptamine Alkaloids; Yohimbine | 1993 |
Cerebral ischemia: from pharmacology to modern techniques and clinical implications. Value of almitrine-raubasin (Duxil Duxaril). International symposium, Hangzhou, People's Republic of China, May 14, 1994.
Topics: Almitrine; Brain Ischemia; Drug Combinations; Humans; Neuroprotective Agents; Piperazines; Secologanin Tryptamine Alkaloids; Yohimbine | 1995 |
Glial fibrillary acidic protein expression after transient brain ischemia: evidence for a pharmacological modulation by almitrine-raubasine.
Topics: Almitrine; Animals; Carotid Artery Diseases; Constriction; Drug Combinations; Gerbillinae; Glial Fibrillary Acidic Protein; Hippocampus; Ischemic Attack, Transient; Male; Secologanin Tryptamine Alkaloids; Yohimbine | 1995 |
Stroke and functional rehabilitation: the Chinese experience.
Topics: Aged; Aged, 80 and over; Aging; Almitrine; Cerebrovascular Disorders; China; Drug Combinations; Female; Humans; Incidence; Male; Middle Aged; Neuroprotective Agents; Prevalence; Yohimbine | 1998 |
[Effect of almitrine/raubasine on cerebral metabolism in the elderly].
Topics: Aged; Almitrine; Alzheimer Disease; Animals; Brain; Brain Ischemia; Energy Metabolism; Humans; Neurons; Nootropic Agents; Oxygen Consumption; Secologanin Tryptamine Alkaloids; Yohimbine | 2002 |